Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ivabradine extended release - Abbott Healthcare

Next Previous
Drug Profile

Ivabradine extended release - Abbott Healthcare

Alternative Names: Ivabradine prolonged release

Latest Information Update: 06 Jan 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Abbott Healthcare
  • Class Benzazepines; Bradycardic agents; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Small molecules
  • Mechanism of Action Hyperpolarisation activated cation channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Angina pectoris; Chronic heart failure

Most Recent Events

  • 06 Jan 2023 No development reported - Phase-III for Chronic heart failure in India (PO)
  • 28 Nov 2019 No recent reports of development identified for phase-I development in Angina-pectoris(In volunteers) in India (PO, Controlled release)
  • 21 May 2018 Abbott Healthcare plans a phase III trial in stable Chronic heart failure (in patients with systolic dysfunction) in India (PO, Controlled release) (CTRI2018-04-013464)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top